Clous

Rocket One Inc.

Nasdaq: HOTH

Pharmaceutical Preparations · Entity-resolved by Clous

CIK0001711786
TickerHOTH
ExchangeNasdaq
SIC2834
StateNV
FY end12-31

Key financials

Revenue
Net IncomeFY2025-12-31
-$12.47M
-52.3% YoY
Total AssetsFY2025-12-31
$7.6M
-1.4% YoY
EquityFY2025-12-31
$6.15M
-10.6% YoY
Shares OutstandingFY2025-12-31
16.26M
Operating Cash FlowFY2025-12-31
-$9.8M
-40.5% YoY

Short interest & fails

Fails-to-deliver
SEC CNS fails · semi-monthly
2.7M
shares failed · 2026-05-28
2026-05-282.7M sh$1.36
2026-05-271.86K sh$0.71
2026-05-211.23K sh$0.60
2026-05-20234.08K sh$0.60
2026-05-195.03K sh$0.61

Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.

AI business summary — latest 10-K

Summary

The filing contains financial reporting tags for Rocket One Inc., focusing on equity incentive plans, stock options, restricted stock awards, and general administrative and research and development expenses for the period ending December 31, 2025.

What it means

The company is tracking significant employee and non-employee equity compensation and operational expenses across multiple incentive plans from 2018 and 2022.

What to watch

Monitor the execution of the ATM Agreement and the impact of stock-based compensation on future dilution.

Generated from public filings · not investment advice

ConceptFY2022-12-31FY2023-12-31FY2024-12-31FY2025-12-31YoY% rev
Net Income-$11.37M-$7.85M-$8.19M-$12.47M-52.3%
Total Assets$6.76M$9.52M$7.71M$7.6M-1.4%
Equity$5.12M$8.82M$6.88M$6.15M-10.6%
Operating Cash Flow-$9.3M-$8.45M-$6.98M-$9.8M-40.5%
Shares Outstanding16.26M
Source: SEC EDGAR · resolved by Clous · as of 2026-05-30Warehouse synced 2026-06-20 06:30 UTC

Get this entity — and 970.89K+ others — programmatically.

One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.

GET /v1/entities?cik=0001711786